The global demand for c-reactive protein test Market is presumed to reach the valuation of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2020 - 2027.
A c-reactive protein test measures c-reactive protein test (CRP) in the patient's blood. The test is performed to find or monitor conditions that cause inflammation due to bacterial infections, fungal infection, inflammatory bowel disease, an autoimmune disorder, or bone infection. CRP is a protein produced by the liver. It is classified as an acute-phase reactant, which means that its levels will rise in response to inflammation. CRP is not typically detected in the blood unless some degree of inflammation is present in the body.
The rising prevalence of chronic conditions, an autoimmune disorder, bone infection, bacterial and fungal infection is steering the global c-reactive protein testing market's growth. The increasing aging population is estimated to fuel the market in the forecast period. In 2019, there were 703 million persons aged above 65 years. The figure is projected to double to 1.5 billion in 2050. Extensive research is being conducted on various applications of the C-reactive protein (CRP) testing to develop novel techniques to measure C-reactive protein test concentration.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each segment in the global market of c-reactive protein test.
This section of the c-reactive protein test market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.
By Assay Type
By Detection Range
- Immunoturbidimetric Assay
- Chemiluminescence Immunoassay
By Disease Area
- Conventional CRP
By End Use
- Cardiovascular Diseases
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Assisted Living Healthcare Facilities
This section covers regional segmentation which accentuates on current and future demand for c-reactive protein test market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe C-Reactive Protein Test Market by Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the c-reactive protein test market include Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Danaher, Quest Diagnostics Incorporated, Siemens, Abbott Laboratories, Laboratory Corporation of America Holdings, Merck KGaA, Abaxis, Inc., Ortho Clinical Diagnostics.S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.